RTW Investments’s Nuvation Bio NUVB Stock Holding History

RTW Investments’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300,000	Closed	-$3.13M	–	119
2021 Q1	$3.13M	Buy	+300,000	New	+$3.35M	0.05%	97

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

RTW Investments's NUVB Position: Q2 2021 in Review

RTW Investments sold out of Nuvation Bio (NUVB) in Q2 2021, closing a stake of 300,000 shares — an estimated $3.13M sold.

RTW Investments first reported a position in NUVB in Q1 2021 and held it in 1 quarter. The position peaked at $3.13M in Q1 2021. 99 funds tracked by Wall St. Rank hold NUVB as of Q2 2021.

RTW Investments reported no remaining Nuvation Bio position as of Q2 2021 after selling out during the quarter.
RTW Investments sold 300,000 Nuvation Bio shares in Q2 2021, an estimated $3.13M.
RTW Investments first reported a position in Nuvation Bio in Q1 2021 and held it in 1 quarter.
RTW Investments's Nuvation Bio position peaked at $3.13M in Q1 2021.
99 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2021.

Based on RTW Investments's 13F filing for Q2 2021, filed 13 Aug 2021.